Composition

Each 1 ml contains:
Latanoprost ............................ 50 μg
Inactive ingredients: Benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous, polysorbate 80, water for injection.

Therapeutic Indications

Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.

Dosage and Administration:

Recommended dosage for Adults (including the Elderly):
Recommended therapy is: One eye drop in the affected eye(s) once daily. Optimal effect is obtained if Xalatrex is administered in the evening.
The dosage of Xalatrex should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect.
If one dose is missed, treatment should continue with the next dose as normal.
As with any eye drops, to reduce possible systemic absorption, it is recommended that the lacrimal sac be compressed at the medial canthus (punctal occlusion) for one minute. This should be performed immediately following the instillation of each drop.
Contact lenses should be removed before instillation of Xalatrex and may be reinserted after 15 minutes.
If more than one topical ophthalmic drug is being used, the drugs should be administered at least five minutes apart.
Children:
Safety and effectiveness in children has not been established. Therefore, Xalatrex is not recommended for use in children.

Contraindications:

Known hypersensitivity to any component in Xalatrex